Literature DB >> 35780236

Interaction mechanism of novel fluorescent antifolates targeted with folate receptors α and β via molecular docking and molecular dynamic simulations.

Cuihong Wang1, Meiling Zhang2, Shuhui Shi3, Yue Jiang4, Xuening Fei5, Lijuan Liu4, Dan Ye4, Shouchao Zhang4.   

Abstract

Eight novel fluorescent antifolates were designed and docked with folate receptors FRα and FRβ. The structures of the complexes were further calculated by molecular dynamic (MD) simulations. The binding energies were calculated by molecular docking and molecular mechanics Poisson-Boltzmann surface area (MM-PBSA) studies. The binding energy differences between FRα and FRβ (|Ebα|-|Ebβ|) values for compounds 3 and 8 were 1.3 and 1.1 kcal/mol calculated by molecular docking, and 13.9 and 10.4 kcal/mol by MM-PBSA simulation, respectively. The results indicated that compounds 3 and 8 may be the best candidates for targeted drug delivery to FRα. The binding structures, interaction residues, negatively charged pocket volume, and surface area were analyzed for all the complexes. We further calculated the root mean square displacement and secondary structural elements of the bound complexes using molecular dynamics simulations. The purpose of this study is to design novel antifolates targeted to FRα and FRβ, and to further distinguish between cancer cells and inflammation.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Folate receptor subtype; Molecular docking; Molecular dynamics; Novel antifolate; Target recognition

Mesh:

Substances:

Year:  2022        PMID: 35780236     DOI: 10.1007/s00894-022-05210-y

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  34 in total

1.  Folate receptor allows cells to grow in low concentrations of 5-methyltetrahydrofolate.

Authors:  H Matsue; K G Rothberg; A Takashima; B A Kamen; R G Anderson; S W Lacey
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

2.  Folate-mediated targeting: from diagnostics to drug and gene delivery.

Authors:  C P. Leamon; P S. Low
Journal:  Drug Discov Today       Date:  2001-01-01       Impact factor: 7.851

3.  Imaging of atherosclerosis in apoliprotein e knockout mice: targeting of a folate-conjugated radiopharmaceutical to activated macrophages.

Authors:  Wilfredo Ayala-López; Wei Xia; Bindu Varghese; Philip S Low
Journal:  J Nucl Med       Date:  2010-04-15       Impact factor: 10.057

Review 4.  Folate-targeted immunotherapies: Passive and active strategies for cancer.

Authors:  Batoul Farran; Eluri Pavitra; Prameswari Kasa; Sujatha Peela; Ganji Seeta Rama Raju; Ganji Purnachandra Nagaraju
Journal:  Cytokine Growth Factor Rev       Date:  2019-02-07       Impact factor: 7.638

5.  Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay.

Authors:  Nikki Parker; Mary Jo Turk; Elaine Westrick; Jeffrey D Lewis; Philip S Low; Christopher P Leamon
Journal:  Anal Biochem       Date:  2005-03-15       Impact factor: 3.365

6.  Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages.

Authors:  Amaya Puig-Kröger; Elena Sierra-Filardi; Angeles Domínguez-Soto; Rafael Samaniego; María Teresa Corcuera; Fernando Gómez-Aguado; Manohar Ratnam; Paloma Sánchez-Mateos; Angel L Corbí
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

7.  Tumor Targeting with Novel 6-Substituted Pyrrolo [2,3-d] Pyrimidine Antifolates with Heteroatom Bridge Substitutions via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis.

Authors:  Lalit K Golani; Adrianne Wallace-Povirk; Siobhan M Deis; Jennifer Wong; Jiyuan Ke; Xin Gu; Sudhir Raghavan; Mike R Wilson; Xinxin Li; Lisa Polin; Parker W de Waal; Kathryn White; Juiwanna Kushner; Carrie O'Connor; Zhanjun Hou; H Eric Xu; Karsten Melcher; Charles E Dann; Larry H Matherly; Aleem Gangjee
Journal:  J Med Chem       Date:  2016-08-26       Impact factor: 7.446

Review 8.  Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis.

Authors:  Chrystal M Paulos; Mary Jo Turk; Gert J Breur; Philip S Low
Journal:  Adv Drug Deliv Rev       Date:  2004-04-29       Impact factor: 15.470

Review 9.  Co-opting biology to deliver drugs.

Authors:  Parisa Yousefpour; Ashutosh Chilkoti
Journal:  Biotechnol Bioeng       Date:  2014-07-21       Impact factor: 4.530

Review 10.  Targeted anticancer therapy: overexpressed receptors and nanotechnology.

Authors:  Mohd Javed Akhtar; Maqusood Ahamed; Hisham A Alhadlaq; Salman A Alrokayan; Sudhir Kumar
Journal:  Clin Chim Acta       Date:  2014-05-15       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.